Psychedelic Stocks Focusing On Psychedelics Revival And Its Impact On Neuroscience By Larry Zweig April 07, 2021 A brain-computer interface (BCI) pioneer known as Kernel has disclosed details about its plan to collaborate with Cybin, which happens to be a biotech company based in Toronto. The new partnership will see the two parties focus on...
Spotlight Stock Cybin Inc (OTCMKTS:CLXPF) Raised $34.3 Million To Advance Its Novel Molecule Programs And Technologies By Larry Zweig February 19, 2021 Cybin Inc (OTCMKTS:CLXPF) has released financial results and business updates for its third quarter. The biotechnology company specializes in the development of progressing psychedelic therapeutics. The company announced a success...
